CRISPR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade CRISPR 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. 

CEO
Samarth Kulkarni
CEOSamarth Kulkarni
Employees
Employees
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2013
Founded2013
Employees
Employees

CRSP Key Statistics

Market cap
5.47B
Market cap5.47B
Price-Earnings ratio
-11.88
Price-Earnings ratio-11.88
Dividend yield
Dividend yield
Average volume
1.74M
Average volume1.74M
High today
$59.34
High today$59.34
Low today
$55.63
Low today$55.63
Open price
$57.98
Open price$57.98
Volume
3.38M
Volume3.38M
52 Week high
$78.48
52 Week high$78.48
52 Week low
$44.12
52 Week low$44.12

Stock Snapshot

With a market cap of 5.47B, CRISPR(CRSP) trades at $57.00. The stock has a price-to-earnings ratio of -11.88.

As of 2026-09-19, CRISPR(CRSP) stock has fluctuated between $55.63 and $59.34. The current price stands at $57.00, placing the stock +2.5% above today's low and -3.9% off the high.

CRISPR(CRSP) shares are trading with a volume of 3.38M, against a daily average of 1.74M.

During the past year, CRISPR(CRSP) stock moved between $44.12 at its lowest and $78.48 at its peak.

During the past year, CRISPR(CRSP) stock moved between $44.12 at its lowest and $78.48 at its peak.

CRSP News

The Motley Fool 1d
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? - The Motley Fool

...

Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? - The Motley Fool

Analyst ratings

59%

of 22 ratings
Buy
59.1%
Hold
40.9%
Sell
0%

People also own

Based on the portfolios of people who own CRSP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.